RxDoctor Payments Data

Lidia Lidagoster

Psychiatry · New Rochelle, NYNPI 1114903465

Payments from drug & device makers

$2,964in general payments, 2019–2025

Across 43 payments — averaging $68.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$190
  • Neuronetics, Inc.$143
  • Sunovion Pharmaceuticals Inc.$116
  • Lundbeck LLC$46
  • Takeda Pharmaceuticals U.S.A., Inc.$31
  • plus $15 from 1 others

What the payments were for

  • Consulting fees$2,00067%
  • Travel & lodging$331%
  • Food & beverage$93231%

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,964 in reported general payments places this provider in the 85th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$443,537
Medicare patients
52
Services billed
3,108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$99,846
MounjaroTirzepatide76$77,296
Lurasidone Hcl24$18,176
SpravatoEsketamine Hcl16$17,977
Duloxetine Hcl46$1,756
Clonazepam130$1,272
Aripiprazole30$1,053
Quetiapine Fumarate109$1,004
Bupropion XlBupropion Hcl60$788
Oxcarbazepine19$631
Mirtazapine46$610
Fluoxetine Hcl74$603
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine20$596
Eszopiclone26$506
Venlafaxine Hcl ErVenlafaxine Hcl13$504

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$2,423$17,97716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in New Rochelle

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →